# persona_off · bixbench · bix-42-q2

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original**; attempt: **1**.
- Native status: **scored**; normalized native score: **100/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect the supplied files and any repository documentation or existing analysis code, without performing the full analysis yet. Identify the RNA expression file's actual format, dimensions, gene/sample orientation, metadata or nonexpression columns, missing-value encodings, and any documented normalization or transformation. Propose a concise approach to classify the expression distribution as highly/minimally right or left skewed, or approximately normal, specifying the expression scale, pooling versus sample-wise assessment, and planned numerical and graphical diagnostics. Flag consequential uncertainties, especially if the expression scale or intended distribution is undocumented. Explain whether the methylation and clinical files are relevant to this question. Report the inspection and proposed approach for approval.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The brief supplies RNA expression, methylation, and clinical files but no inspected data or documented expression scale. Initial inspection is needed before selecting the distribution assessment.
````

**Objectives Open**

````text
[
  "Inspect inputs and identify the RNA expression values and their scale.",
  "Agree on a defensible approach to characterize skewness.",
  "Execute the approved analysis and provide a concise conclusion with an executed analysis artifact."
]
````

### Event 8 — Actor

**Answer**

````text
Inspection only is complete; distribution analysis has not been performed.

Observed inputs:
- All three .xls files are actually tab-delimited ASCII text with CRLF line endings, not Excel workbooks. The workspace contains only these inputs and task.json; no README, provenance documentation, or existing analysis code was found.
- RNA: 20,502 gene rows × 328 sample columns (329 columns including GeneSymbol), totaling 6,724,656 expression entries. Genes are rows, TCGA aliquots are columns. GeneSymbol is the only nonexpression column; no embedded metadata rows were detected. All rows have the expected width.
- All expression cells parse as finite numbers: no blank/nonnumeric missing tokens, NaN, infinity, or negative values. There are 1,025,144 zeros, which I propose retaining as expression values, not treating as missing. There are 34 repeated gene-symbol occurrences beyond unique symbols, no blank symbols, and no duplicate sample headers; preserve rows rather than silently aggregating symbols.
- Values include decimals (e.g., A1BG starts 22.147, 171.2675, 20.998), so these are not simply integer read counts. No normalization, units, or transformation is documented. The data appear compatible with nonnegative, unlogged abundance values, but a specific normalization such as RSEM/TPM cannot be established from these files.
- Sample barcode type codes are 01:285, 11:41, 02:1, 06:1, so the supplied matrix includes multiple sample types.

Proposed analysis, subject to approval:
1. Read RNA as TSV and use all expression columns and rows on their supplied numerical scale, retaining zeros, duplicate-symbol rows, and all sample types. Do not introduce normalization, log transformation, filtering, or clinical matching into the primary answer.
2. Assess the distribution pooled across gene–sample cells as the primary interpretation of 'distribution of RNA expression data.' Also compute skewness across genes separately for each sample and summarize its median/range and category counts to check whether pooling masks inconsistent sample behavior. This is not a per-gene-across-patients analysis.
3. Calculate bias-corrected Fisher–Pearson skewness, mean/median, relevant quantiles, extrema, and zero fraction. Use a transparent descriptive convention: absolute skewness >1 highly skewed; 0.5–1 minimally/moderately skewed (reported as minimally to match requested categories); <0.5 approximately symmetric, calling it approximately normal only if graphical shape supports that conclusion. Sign determines right versus left. These are heuristic cutoffs, not a hypothesis test.
4. Plot an original-scale full-range histogram, a clearly labeled central-range zoom that does not remove tails from calculations, and a normal Q–Q diagnostic using deterministic subsampling if needed. A log1p-scale histogram/skewness may be included only as a labeled sensitivity diagnostic, never substituted for the primary original-scale result. Avoid formal normality-test p-values on millions of dependent entries.
5. After approval, write and execute a reproducible analysis script, retain numerical summaries/plots, and provide the concise classification with its supporting skewness and an explicit scale qualifier.

Relevance of other inputs: methylation has 20,759 rows × 353 sample columns plus GeneSymbol; clinical has 448 patient rows × 80 columns. Neither is needed to classify RNA expression skewness. Joining them would unnecessarily change the RNA population; they matter only for a separate cross-omics, clinical-stratification, or sample-selection question.

Consequential uncertainties: expression normalization and transformation are undocumented; skewness is scale-dependent. The question does not explicitly distinguish pooled expression, within-sample distributions, or distributions of individual genes across patients. The proposed pooled original-scale answer with sample-wise checks is the most direct reading. No final skewness classification is claimed at this inspection stage.
````

**Stage**

````text
plan
````

**Evidence**

````text
Filesystem inspection found only task.json and three input files. file reported ASCII text with CRLF for each .xls. A complete CSV structural/token audit found RNA row-width counts {329:20502}, 328 unique sample headers, no nonnumeric/nonfinite expression cells, 0 negative entries, 1,025,144 zeros, and 34 duplicate gene-symbol occurrences. No skewness, distribution quantiles, or distribution plots have yet been computed.
````

**Assumptions**

````text
[
  "Primary target is all supplied RNA expression entries on the as-delivered scale; sample-wise distributions are corroborating diagnostics.",
  "Zeros represent expression observations unless contrary provenance emerges; repeated gene symbols remain separate input rows."
]
````

**Uncertainties**

````text
[
  "No normalization, transformation, or expression units are documented.",
  "Intended pooling and sample-type restriction are unspecified; proposed defaults preserve the supplied matrix.",
  "Magnitude category thresholds are descriptive conventions rather than benchmark-specified definitions."
]
````

### Event 9 — Simulator

**Message**

````text
Approved. Execute the proposed original-scale RNA analysis using all supplied expression rows and columns, retaining zeros and repeated gene-symbol rows. Use pooled skewness as the primary descriptive assessment and sample-wise skewness as corroboration; these are reasonable assumptions, not established source intent. Keep the normalization unspecified and do not infer normality from low skewness alone. The proposed numerical summaries and original-scale plots are sufficient; the log1p sensitivity diagnostic is optional. No clinical or methylation join is needed. Report the observed classification concisely, with the numerical skewness and supplied-scale qualifier, and summarize whether sample-wise diagnostics agree. Retain the executed reproducible script or notebook and provide its path in artifacts.analysis; set payload.executed_analysis=true only after execution.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
The reported structural audit identifies a finite, nonnegative 20,502-by-328 expression matrix with no documented units or transformation. The proposed analysis preserves the input population, explicitly distinguishes scale and pooling assumptions, and uses numerical and graphical diagnostics appropriate to the requested descriptive classification.
````

**Objectives Open**

````text
[
  "Execute the distribution analysis and determine direction and magnitude of skewness on the supplied RNA scale.",
  "Report supporting pooled and sample-wise diagnostics and retain an executed analysis artifact.",
  "Provide a concise final answer with executed_analysis status and artifacts.analysis path."
]
````

### Event 14 — Actor

**Answer**

````text
The RNA expression distribution is **highly right-skewed on the supplied expression scale**, with pooled bias-corrected skewness **42.44**. Sample-wise diagnostics agree: all 328 samples are highly right-skewed (skewness range **11.47–110.80**, median **20.63**).
````

**Stage**

````text
result
````

**Evidence**

````text
Executed python analysis.py successfully (exit code 0). Analysis retained all 20,502 rows × 328 samples (6,724,656 finite entries), including 1,025,144 zeros and repeated gene-symbol rows. Pooled Fisher–Pearson bias-corrected skewness was 42.435713564644885. Mean 931.96 versus median 176.79; 99th percentile 10,879.19; maximum 1,336,107.453. All 328 sample skewness coefficients exceeded 1. Generated a full-range original-scale histogram, a labeled 99th-percentile zoom, and a normal Q–Q plot from a seeded 100,000-cell subset; verified the nonempty PNG, summaries, and executed script exist. A nonfatal fontconfig warning did not prevent plot output.
````

**Assumptions**

````text
[
  "Pooled gene–sample values are the primary descriptive target, with within-sample gene distributions as corroboration; this is an approved interpretation, not documented source intent.",
  "Zeros and repeated gene-symbol rows were retained without normalization, filtering, or joins."
]
````

**Uncertainties**

````text
[
  "Expression units and source normalization/transformation remain undocumented. The classification applies to the supplied numerical scale; a transformed scale may have a different distribution."
]
````

### Event 15 — Simulator

**Message**

````text
The reported analysis adequately answers the question: RNA expression is highly right-skewed on the supplied numerical scale (pooled skewness 42.44), corroborated by all 328 sample-wise distributions. Retain the concise answer, payload.executed_analysis=true, and artifacts.analysis='analysis.py' in the final submission. No revision is needed.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The agent reports successful execution of analysis.py using all 6,724,656 expression entries without filtering or transformation, pooled bias-corrected skewness 42.4357, and sample-wise skewness ranging from 11.47 to 110.80. Reported summaries and retained plots support the classification and match the approved approach. Source normalization remains explicitly undocumented; the conclusion is appropriately restricted to the supplied scale.
````

**Objectives Open**

````text
[]
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/bixbench_bix-42-q2-8b201e9adcdc/persona_off/attempt-1/output/bixbench_bix-42-q2-8b201e9adcdc/controller/events.jsonl",
  "event_log_sha256": "059dfdb99b7cd66231445a05f6b65ccadf747346714c950eb3237cd1a341de0d",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
